In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Anamorelin, the world's first oral drug specifically for the treatment of ca···【more】
Release date:2024-08-21Recommended:314
Koselugois a small molecule drug inhibitor targeting the MEK signaling pathway, ···【more】
Release date:2024-08-21Recommended:281
Koselugois a small molecule inhibitory drug targeting the MEK signaling pathway,···【more】
Release date:2024-08-21Recommended:312
Koselugo, as a small molecule blocker of the MEK signaling pathway, has a core e···【more】
Release date:2024-08-21Recommended:368
Koselugo is a small molecule inhibitor targeting the MEK signaling pathway, main···【more】
Release date:2024-08-21Recommended:341
Koselugo is a small molecule inhibitor targeting MEK, which plays the role of a ···【more】
Release date:2024-08-21Recommended:308
Koselugo is a small molecule MEK inhibitor and a repressor of mitogen activation···【more】
Release date:2024-08-21Recommended:322
Koselugois a small molecule MEK inhibitor (mitogen activation inhibitor), and it···【more】
Release date:2024-08-21Recommended:264
The therapeutic effect of Mitotane is aimed at adrenal cortical carcinoma, hyper···【more】
Release date:2024-08-20Recommended:333
Anamorelin is the first drug specifically for the treatment of cachexia launched···【more】
Release date:2024-08-20Recommended:251
In 2021, Japan launched Anamorelin, the world's first drug specifically for ···【more】
Release date:2024-08-20Recommended:345
Anamorelin is the world's first drug specifically for the treatment of cache···【more】
Release date:2024-08-20Recommended:328